MarketPeel
Insider Trading Intelligence
CW

Conrad Wai

CLOV
CEO, COUNTERPART HEALTH · CLOVER HEALTH INVESTMENTS, CORP. /DE · CIK 0001971702
FILING MIX · LIFETIME16%/84%
BUYS
5
SELLS
26
TOTAL VALUE
$5.82M
COMPANIES
1
ACTIVE SINCE
Jun 2023
HOLDINGS NOW
1,390,056
AVG SELL PX
$2.78
TRADE KIND
SHOWING 31 / 31
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 5 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Conrad Wai, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+100.00%-9.17%+0.45%-9.62%-11.27%
14d3+66.67%-13.21%+0.34%-13.55%-11.35%
30d3+100.00%-22.14%+1.58%-23.72%-21.69%
60d3+100.00%-9.25%+5.01%-14.26%-14.17%
90d3+100.00%-9.66%+6.95%-16.62%-16.07%
180d3+100.00%-20.08%+9.23%-29.31%-30.89%
1y3(2 pending)+0.00%+63.93%+20.53%+43.40%+43.40%
2y3(3 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CLOV · 1,390,056 shares · as of May 28, 2026
0894,5621,789,1232,683,6853,578,246202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 5 buys / 26 sellsCOVERAGE · 13 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE10b5-1
10b5-1 plan
220,426$3.99$879.5K1,390,056May 28, 2026May 28, 2026View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Counterpart Health
23,463$2.04$47.9K1,169,914Apr 15, 2026Apr 16, 2026View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
PURCHASEGRANT
Stock grant
267,7661,193,377Apr 1, 2026Apr 3, 2026View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Counterpart Health
100,195$1.98$198.4K925,611Mar 14, 2026Mar 17, 2026View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Counterpart Health
25,868$2.81$72.7K1,025,806Jan 15, 2026Jan 20, 2026View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Counterpart Health
98,411$2.70$265.7K1,051,674Dec 14, 2025Dec 16, 2025View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Counterpart Health
96,448$3.53$340.5K1,178,015Oct 31, 2025Nov 4, 2025View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Counterpart Health
27,930$3.53$98.6K1,150,085Oct 31, 2025Nov 4, 2025View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Counterpart Health
92,181$2.80$258.1K1,274,463Oct 15, 2025Oct 17, 2025View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Counterpart Health
98,412$3.06$301.1K1,573,425Sep 14, 2025Sep 16, 2025View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Counterpart Health
27,930$2.89$80.7K1,671,837Jul 31, 2025Aug 4, 2025View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE10b5-1
10b5-1 plan
91,197$3.32$302.8K1,403,701Jul 23, 2025Jul 24, 2025View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE10b5-1
10b5-1 plan
118,600$3.29$390.2K1,494,898Jul 22, 2025Jul 24, 2025View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE10b5-1
10b5-1 plan
15,203$3.26$49.6K1,613,498Jul 8, 2025Jul 10, 2025View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Counterpart Health
98,411$2.89$284.4K3,138,535Jun 14, 2025Jun 17, 2025View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Counterpart Health
26,593$3.40$90.4K3,236,946Apr 30, 2025May 2, 2025View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Counterpart Health
80,524$3.66$294.7K3,263,539Mar 14, 2025Mar 18, 2025View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Counterpart Health
24,470$4.39$107.4K3,344,063Jan 31, 2025Feb 4, 2025View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Counterpart Health
98,217$3.11$305.5K3,368,533Dec 14, 2024Dec 17, 2024View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Counterpart Health
111,496$4.12$459.4K3,466,750Oct 31, 2024Nov 4, 2024View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
PURCHASEGRANT
Stock grant
726,1143,578,246Oct 15, 2024Oct 17, 2024View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
Chief Technology Officer
98,217$2.99$293.7K2,852,132Sep 14, 2024Sep 17, 2024View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
PURCHASEGRANT
Stock grant
379,8661,699,767Sep 13, 2024Jul 10, 2025View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
PURCHASEGRANT
Stock grant
189,9343,043,529Sep 13, 2024Sep 17, 2024View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
Chief Technology Officer
93,180$2.99$278.6K2,950,349Sep 13, 2024Sep 17, 2024View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
Chief Technology Officer
69,148$1.09$75.4K2,853,595Jun 14, 2024Jun 18, 2024View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
Chief Technology Officer
74,396$0.73$54.3K2,922,743Mar 14, 2024Mar 18, 2024View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
Chief Technology Officer
96,086$1.00$96.1K2,997,139Dec 14, 2023Dec 18, 2023View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
PURCHASEGRANT
Stock grant
440,0003,093,225Oct 31, 2023Nov 3, 2023View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
Chief Technology Officer
96,086$1.13$108.6K2,653,225Sep 14, 2023Sep 18, 2023View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
Chief Technology Officer
86,763$0.94$81.6K2,749,311Jun 14, 2023Jun 16, 2023View →
Other insiders · CLOV
Loading peer insiders…
About this filer
CIK 0001971702
ROLE
CEO, Counterpart Health
PRIMARY
CLOV
COMPANIES
1
ACTIVE SINCE
Jun 2023
MARKETPEEL · /INSIDER/0001971702DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback